Coeptis Therapeutics Holdings, Inc.
COEP
$9.67
-$0.08-0.82%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 43.18% | 18.27% | 38.11% | 43.40% | 45.41% |
| Total Depreciation and Amortization | -0.24% | 3.00% | 3.01% | 3.02% | -13.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.32% | -49.72% | -71.04% | -66.12% | -61.17% |
| Change in Net Operating Assets | 1,218.27% | 677.03% | 446.19% | 414.67% | 89.55% |
| Cash from Operations | -8.03% | -27.51% | -62.17% | -86.79% | -97.49% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 171.43% | -- | -- | -100.00% |
| Cash from Investing | -- | 171.43% | -- | -- | -100.00% |
| Total Debt Issued | 300.00% | -126.27% | -- | -- | 110.53% |
| Total Debt Repaid | 68.67% | 16.36% | 30.20% | 49.32% | -244.66% |
| Issuance of Common Stock | -36.42% | -4.67% | -18.92% | -37.88% | -65.83% |
| Repurchase of Common Stock | -71,328.57% | -64,185.71% | -- | -- | 99.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 213.90% | 213.90% | 132.54% | 132.54% | -348.62% |
| Cash from Financing | 1,452.34% | -24.71% | 48.57% | -10.39% | -90.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 95.40% | -295.01% | -354.68% | -244.07% | -230.66% |
